Related Experiment Video
Updated: Aug 16, 2025
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Pearls & Oy-sters: Salt and Pepper Sign, PLNTY for Drug-Resistant Epilepsy.
Elma M Paredes-Aragón1, Norah A AlKhaldi2, Jorge G Burneo2
1From the Departments of Clinical Neurological Sciences (E.M.P.-A., J.G.B., D.L., L.C.A., D.S., S.M.M.), Department of Clinical Neurological Sciences and Oncology (M.M), Epidemiology and Biostatistics (J.G.B., D.S.), Pathology and Laboratory Medicine (L.C.A.), Medical Imaging (S.M.M.), Medical Biophysics (S.M.M.), and Psychology (S.M.M.), Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; Department of Neurological Emergencies (E.M.P.-A.), National Institute of Neurology and Neurosurgery, Mexico City, Mexico; Department of Neurology (N.A.A.), King Fahad University Hospital, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; and Epilepsy Department (M.H.-A.), Neurology Division, Instituto Nacional de Ciencias Neurológicas, Lima, Peru. elma.paredesaragon@lhsc.on.ca.
Drug-resistant epilepsy, often caused by tumors, can be challenging to treat. Polymorphic low-grade neuroepithelial tumor of the young (PLNTY) is a newly identified, highly epileptogenic tumor subtype with distinct genetic and imaging features.
Area of Science:
- Neurology
- Neuro-oncology
- Pathology
Background:
- Drug-resistant epilepsy affects two-thirds of epilepsy cases.
- Tumors account for a significant proportion of adult and childhood-onset epilepsies.
- Traditional tumor classifications for epilepsy are evolving with genetic insights.
Purpose of the Study:
- To introduce and characterize Polymorphic low-grade neuroepithelial tumor of the young (PLNTY) as a distinct, highly epileptogenic tumor subtype.
- To highlight the diagnostic challenges and unique features of PLNTY tumors.
- To differentiate PLNTY from other low-grade gliomas based on pathological and genetic markers.
Main Methods:
- Review of pathological and genetic findings in epilepsy-associated tumors.
- Analysis of imaging characteristics, including MRI FLAIR (salt and pepper sign) and CT head calcifications.
- Immunohistochemical staining for CD34.
Main Results:
- PLNTY tumors exhibit oligodendroglioma-like cellular components and infiltration patterns.
- A strong CD34-immunopositive stain is a key diagnostic clue for PLNTY.
- Characteristic radiologic findings include the 'salt and pepper sign' on MRI FLAIR and calcifications on CT.
Conclusions:
- PLNTY represents a distinct, highly epileptogenic tumor entity.
- Integrated pathological, genetic, and radiological analysis is crucial for accurate PLNTY diagnosis.
- Identification of PLNTY aids in understanding and potentially managing drug-resistant epilepsy cases linked to specific tumor types.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:14Antiepileptic Drugs: Glutamate Antagonists
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...